CN110141660A - 鼠疫菌f1疫苗液体气溶胶肺递送免疫小鼠模型 - Google Patents
鼠疫菌f1疫苗液体气溶胶肺递送免疫小鼠模型 Download PDFInfo
- Publication number
- CN110141660A CN110141660A CN201810270743.9A CN201810270743A CN110141660A CN 110141660 A CN110141660 A CN 110141660A CN 201810270743 A CN201810270743 A CN 201810270743A CN 110141660 A CN110141660 A CN 110141660A
- Authority
- CN
- China
- Prior art keywords
- vaccine
- plague
- lung
- mouse
- bacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810270743.9A CN110141660A (zh) | 2018-03-29 | 2018-03-29 | 鼠疫菌f1疫苗液体气溶胶肺递送免疫小鼠模型 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810270743.9A CN110141660A (zh) | 2018-03-29 | 2018-03-29 | 鼠疫菌f1疫苗液体气溶胶肺递送免疫小鼠模型 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110141660A true CN110141660A (zh) | 2019-08-20 |
Family
ID=67588299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810270743.9A Pending CN110141660A (zh) | 2018-03-29 | 2018-03-29 | 鼠疫菌f1疫苗液体气溶胶肺递送免疫小鼠模型 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110141660A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114794018A (zh) * | 2022-06-28 | 2022-07-29 | 北京赛尔富森生物科技有限公司 | 一种腮腺炎病毒攻毒动物模型及其建立方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015004627A1 (en) * | 2013-07-12 | 2015-01-15 | The Catholic University Of America | Mutated and bacteriophage t4 nanoparticle arrayed f1-v immunogens from yersina pestis as next generation plague vaccines |
CN107753144A (zh) * | 2016-08-18 | 2018-03-06 | 中国人民解放军军事医学科学院微生物流行病研究所 | 手持式液体气溶胶肺递送装置 |
-
2018
- 2018-03-29 CN CN201810270743.9A patent/CN110141660A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015004627A1 (en) * | 2013-07-12 | 2015-01-15 | The Catholic University Of America | Mutated and bacteriophage t4 nanoparticle arrayed f1-v immunogens from yersina pestis as next generation plague vaccines |
CN107753144A (zh) * | 2016-08-18 | 2018-03-06 | 中国人民解放军军事医学科学院微生物流行病研究所 | 手持式液体气溶胶肺递送装置 |
Non-Patent Citations (4)
Title |
---|
JOANNE HUANG等: "Protective Immunity in Mice Achieved with Dry Powder Formulation and Alternative Delivery of Plague F1-V Vaccine", 《CLINICAL AND VACCINE IMMUNOLOGY》 * |
MAYTAL BIVAS-BENITA等: ""Non-invasive pulmonary aerosol delivery in mice by the endotracheal route"", 《EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS》 * |
秦川等主编: "《常见和新发传染病动物模型》", 31 January 2012, 中国协和医科大学出版社 * |
耿贯一主编: "《流行病学(上册)》", 31 December 1979, 人民卫生出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114794018A (zh) * | 2022-06-28 | 2022-07-29 | 北京赛尔富森生物科技有限公司 | 一种腮腺炎病毒攻毒动物模型及其建立方法 |
CN114794018B (zh) * | 2022-06-28 | 2022-11-04 | 北京赛尔富森生物科技有限公司 | 一种腮腺炎病毒攻毒动物模型及其建立方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dowling et al. | Experimental induction of pneumonic pasteurellosis in calves by intratracheal infection with Pasteurella multocida biotype A: 3 | |
Flynn et al. | Immune cell interactions in tuberculosis | |
Alphandéry | The potential of various nanotechnologies for coronavirus diagnosis/treatment highlighted through a literature analysis | |
Zaman et al. | Novel platform technology for modular mucosal vaccine that protects against streptococcus | |
Granum et al. | IgE adjuvant effect caused by particles—immediate and delayed effects | |
Hsueh et al. | Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles | |
Tukhvatulin et al. | Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates | |
Giese | Introduction to molecular vaccinology | |
Collier et al. | The antigenicity of ultra-violet irradiated vaccinia virus | |
Alabdullah et al. | Evaluation of the efficacy of a cholera toxin-based staphylococcus aureus vaccine against bovine intramammary challenge | |
Barlough et al. | Experimental inoculation of cats with human coronavirus 229E and subsequent challenge with feline infectious peritonitis virus. | |
CN110141660A (zh) | 鼠疫菌f1疫苗液体气溶胶肺递送免疫小鼠模型 | |
Shlyakhov et al. | Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern | |
Tabynov et al. | Safety of the novel vector vaccine against Brucella abortus based on recombinant influenza viruses expressing Brucella L7/L12 and OMP16 proteins, in cattle | |
Zhang et al. | Studies on the level of neutralizing antibodies produced by inactivated COVID-19 vaccines in the real world | |
CN110075286A (zh) | 用于抗细胞内病原体的治疗的包含固体纳米颗粒和至少一种抗原的药物组合物 | |
CN102279257A (zh) | 一种用于诊断人或动物的免疫相关性疾病的试剂盒 | |
CN110151793A (zh) | 鼠疫菌液体气溶胶肺递送感染小鼠模型 | |
Wei et al. | Generation and immunogenicity analysis of recombinant classical swine fever virus glycoprotein E2 and E rns expressed in baculovirus expression system | |
CN108392498A (zh) | 布鲁菌减毒活疫苗液体气溶胶肺递送免疫小鼠模型 | |
Martínez-Martínez et al. | Acute phase protein concentrations in colostrum-deprived pigs immunized with subunit and commercial vaccines against Glässer's disease | |
Li et al. | Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer | |
Howell et al. | Immunomodulatory effect of endotoxin on the development of latex allergy | |
Alshanqiti et al. | Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid | |
CN110354147A (zh) | 布鲁氏菌液体气溶胶肺递送感染小鼠模型的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Lingfei Inventor after: Yin Zhe Inventor after: Yang Wenhui Inventor after: Jiao Jun Inventor after: Jin Aijun Inventor after: Xiong Xiaolu Inventor after: Zhao Yuee Inventor after: Yu Xuedong Inventor after: Jiao Zhouguang Inventor after: Zhou Dongsheng Inventor after: Feng Junxia Inventor after: Sun Yansong Inventor after: Qiu Yefeng Inventor after: Gao Bo Inventor after: Fa Yunzhi Inventor after: Wang Xiaoyi Inventor after: Yang Huiying Inventor before: Feng Junxia Inventor before: Yin Zhe Inventor before: Hu Lingfei Inventor before: Jiao Jun Inventor before: Jin Aijun Inventor before: Xiong Xiaolu Inventor before: Zhao Yuee Inventor before: Yu Xuedong Inventor before: Jiao Zhouguang Inventor before: Yang Wenhui Inventor before: Zhou Dongsheng Inventor before: Sun Yansong Inventor before: Qiu Yefeng Inventor before: Gao Bo Inventor before: Fa Yunzhi Inventor before: Wang Xiaoyi Inventor before: Yang Huiying |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190820 |
|
RJ01 | Rejection of invention patent application after publication |